NDC 87021-102 - SACCHAROMYCES BOULARDII

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 87021-102
Package NDCs from labels: 87021-102-30
Manufacturer: Krewe Pharma, LLC
Effective date: 2025-09-08
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
SACCHAROMYCES BOULARDII - Krewe Pharma, LLC	Krewe Pharma, LLC	2025-09-08	DIETARY SUPPLEMENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
87021-102-30	SACCHAROMYCES BOULARDII	30 in 1 BOTTLE	CAPSULE	30		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
87021-102-30	EA - Each	87021-102	c25df708-0e66-4dfe-86ba-ab0936dd6591	1	2025-11-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Urea 40	UREA	Krewe Pharma, LLC	415c4efd-95bd-4276-900c-e9da70266cd4	2026-06-02	Warnings	Name fallback manufacturer name: Krewe Pharma, LLC
Urea 39	UREA	Krewe Pharma, LLC	be19358f-67a8-4a0d-88e0-91eb4cb42e0d	2026-06-02	Warnings	Name fallback manufacturer name: Krewe Pharma, LLC

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.